ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

PRXL Parexel International Corp.

88.08
0.00 (0.00%)
30 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Parexel International Corp. NASDAQ:PRXL NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 88.08 88.10 88.11 0 01:00:00

PAREXEL International Announces Date Of Third Quarter Fiscal Year 2015 Earnings Release And Conference Call

16/03/2015 1:00pm

PR Newswire (US)


Parexel (NASDAQ:PRXL)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Parexel Charts.

BOSTON, March 16, 2015 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL) will release financial results for the Third Quarter of Fiscal Year 2015 on Wednesday, April 29th, 2015 after the close of the stock market.  The announcement will be available on PAREXEL's website at www.PAREXEL.com and on the PRNewswire website at www.prnewswire.com.

PAREXEL will host a conference call and live webcast at 10:00 a.m. EDT on Thursday, April 30th, 2015 to discuss the results.  To access the webcast, visit PAREXEL's website at www.PAREXEL.com, and click on the Investors menu.  This webcast will continue to be accessible for one year following the live broadcast.  To participate via telephone, dial (408) 940-3886 and ask to join PAREXEL's Third Quarter Fiscal Year 2015 conference call.

About PAREXEL International

PAREXEL International Corporation is a leading global biopharmaceutical services organization, providing a broad range of expertise-based contract research, consulting, medical communications, and technology solutions and services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. PAREXEL Informatics, Inc. provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates in 81 locations in 51 countries around the world, and has approximately 16,530 employees.  For more information about PAREXEL International visit www.PAREXEL.com.

PAREXEL is a trademark or registered trademark of PAREXEL International Corporation or its affiliates.

CONTACTS: Jill Baker, Corporate Vice President of Investor Relations +1-781-434-4118

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/parexel-international-announces-date-of-third-quarter-fiscal-year-2015-earnings-release-and-conference-call-300050392.html

SOURCE PAREXEL International Corporation

Copyright 2015 PR Newswire

1 Year Parexel Chart

1 Year Parexel Chart

1 Month Parexel Chart

1 Month Parexel Chart

Your Recent History

Delayed Upgrade Clock